🇦🇹 Austria Country × Condition
ulcerative colitis Clinical Trials in Austria
Active clinical trials for ulcerative colitis with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇦🇹 Austria
Active Trials in Austria (2)
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Enrollment
252 pts
Country
🇦🇹 Austria
Eli Lilly and Company
View Trial → NCT06937086 Phase 3
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Enrollment
350 pts
Country
🇦🇹 Austria
Eli Lilly and Company
View Trial → Frequently Asked Questions
How many ulcerative colitis clinical trials are active in Austria?
There are currently 2 active clinical trials for ulcerative colitis with sites in Austria, of which 2 are actively recruiting patients.
How can I join a ulcerative colitis clinical trial in Austria?
To join a ulcerative colitis clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ulcerative colitis trials in Austria?
Active ulcerative colitis trials in Austria span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology